Socio-demographic profile of multi-drug resistant tuberculosis patients and its association with severity of adverse drug reactions in DOTS plus centre at tertiary hospital in Himachal Pradesh, India
Keywords:Multi-drug resistant tuberculosis, Severity of adverse drug reactions, Socio-demographic profile
Background: Multi-drug resistant tuberculosis has become major public health problem and obstacle to effective control of tuberculosis. Objectives was to study the socio-demographic profile of multi- drug resistant tuberculosis patients and its association with severity of ADR (adverse drug reactions) in DOTS plus centre at tertiary hospital in Himachal Pradesh.
Methods: It was a prospective observational study carried out from November 2012 to October 2013 on multi-drug resistant tuberculosis (MDR-TB) patients after approved from Institutional Ethics Committee.
Results: Out of 104 patients the mean age of patients was 39.9 ±14.26 years. Majority of the patients were in the economically productive age groups. Multi-drug resistant tuberculosis was more in male (76%) than female (24%) and 96% of patients were belonged to rural area. The educational status of the MDR-TB shows 24% patients were illiterate. 63.46% MDR-TB patients were underweight (BMI<18.5%) according to WHO guidelines for obesity. Severity of ADR assessed by Hart wig and Siegel’s scale showed 21% patients experienced mild ADRs, 49% patients had moderate and 17% patients had severe ADRs. Severity of ADR is seen more in male, economically productive age group, subjects on vegetarian diet, patients who were underweight (BMI<18.5%) and with lower educational status.
Conclusions: MDR-TB is a rapidly increasing health problem with major socio-economic and individual consequences. Multi-drug resistant tuberculosis mainly affects middle age that is in the economically productive age group which hampers the social and economic development of individual, society and nation.
World health organization, Global TB report 2017. Available at: www.who.Int/tb/Publication/global_report2017/en/index.html. Accessed on 08 July 2018.
Morris MD, Quenza L, Bhat P, Moser K, Smith J, Perez H, et al. Social, economic and psychological Impacts of MDR-TB treatment. Int J Tuberc Lung Dis. 2013;17(7): 954-60.
Central TB Division (CTD), Directorate General of Health services, Ministry of Health and Family Welfare, Government of India, Programmatic Management of Drug Resistant TB (PMDT) Guidelines 2017. CTD, New Delhi.
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229-32.
The use of the WHO-UMC system for standardized case causality assessment. Available at: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf.Accessed on 9 September 2018.
World health organization. Fact sheet: obesity and overweight; 2018. Available at: http://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. Accessed on 9 September 2018.
Sharma SK, Kumar S, Saha PK, George N, Arora SK, Gupta D, et al. Prevalence of multidrug-resistant tuberculosis among category II pulmonary tuberculosis patients. Indian J Med Res. 2011;133:312-5.
Bhatt G, Vyas S, Trivedi K. An epidemiological study of multi drug resistant tuberculosis. Indian J Tuberc. 2012;59(1):18-27.
Thomas A, Ramachandran R, Rehaman F, Jaggarajamma K, Santha T, Selvakumar N, et al. Management of multi drug resistance tuberculosis in the field. Indian J Tuberc. 2007;54:117-24.
Himachal Pradesh population census; 2011. Available at: https://www.censusindia.co.in/states/himachal-pradesh. Accessed on 9 September 2018.
Mishra VK, Gupt P, Pachar P, Jangir SK, Gupta RC, Gour N. A study to assess the profile of multidrug-resistant tuberculosis (MDR-TB) in tertiary care hospital setting. Sch J App Med Sci. 2016;4(3):820-27.
Mukherjee P, Karmakar PR, Basu R, Lahiri SK. Sociodemographic and clinical profile of multi drug resistant tuberculosis patients: a study at drug resistant tuberculosis. JDMS. 2015;14(8):52-8.
Wahab F, Ashraf S, Khan N, Anwar R and Afridi MZ. Risk factors for multi-drug resistant tuberculosis in patients. J Coll Physicians Surg Pak. 2009;19(3):162-4.